ArticleJTO clinical and research reports2026

SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.

Catherine A Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.